Bruker said the new agreement would allow it to develop the platform for use in pathology labs, including building clinically validated content libraries.
C4BPA could prove useful as a diagnostic biomarker for early stage pancreatic cancer and to help differentiate the disease from other cancers.
Some six months after establishing itself as an independent entity, the company plans to roughly double its protein biomarker libraries by the end of the year.
Among the launches at the organization's annual meeting this week in Taipei were a personalized proteomics initiative and a new DIA mass spec method.
The partners will collaborate on pilot studies evaluating the Avatar system and analytics platform in the immunoprofiling of cancer patients.
In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.
Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.
Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.
Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.